Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy

被引:58
作者
Bachar, Gideon Y. [1 ,2 ]
Goh, Christopher [1 ,2 ]
Goldstein, David P. [1 ,2 ]
O'Sullivan, Brian [3 ]
Irish, Jonathan C. [1 ,2 ]
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
关键词
Tonsillar carcinoma; Salvage; Surgery; Radical radiotherapy; Outcome; SQUAMOUS-CELL CARCINOMA; PRIMARY CONCOMITANT CHEMORADIATION; HUMAN-PAPILLOMAVIRUS INFECTION; NECK-CANCER; DEFINITIVE RADIOTHERAPY; RADIATION-THERAPY; PRIMARY HEAD; SURGERY; REIRRADIATION; CHEMOTHERAPY;
D O I
10.1007/s00405-009-1070-0
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The objective of this study is to report the long-term outcomes of salvage surgery following local and/or regional failure of tonsillar carcinoma treated with standard fractionation radiotherapy. All cases of carcinoma of the tonsil treated by radical radiotherapy at the Princess Margaret Hospital between January 1970 and December 1990 were reviewed retrospectively. Patients who underwent salvage surgery for local and/or regional recurrent squamous cell carcinoma of the tonsil following radiation therapy were included for analysis. 239 out of 640 patients with tonsillar carcinoma recurred post radiotherapy. 175 patients were deemed candidates for surgical salvage. At the time of the last follow-up, only 13 patients were alive and 162 patients had died. The majority of patients (n = 96, 59%) died with disease. The median time to death was approximately 1.3 years following salvage surgery. The 5-year overall survival rate was 23%. The 5-year cause-specific survival was 40%. The probability of death due to disease was higher than the probability of death due to other causes. Both N-classification and T-classification were found to be significant predictors of time to death. In conclusion, in spite of the fact that the patients in this study had been treated prior to the widespread introduction of altered fractionation and concurrent chemoradiation for advanced tonsil carcinoma, it demonstrates the poor prognosis of recurrent disease. Despite the poor prognosis, 20% of patients will be alive at 5 years and therefore salvage surgery should be considered when possible.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 41 条
[1]   Oropharyngeal carcinoma in non-smokers and non-drinkers: A role for HPV [J].
Andrews, Elizabeth ;
Seaman, William T. ;
Webster-Cyriaque, Jennifer .
ORAL ONCOLOGY, 2009, 45 (06) :486-491
[2]   A MULTIVARIATE PRIMARY TUMOR-CONTROL ANALYSIS IN 465 PATIENTS TREATED BY RADICAL RADIOTHERAPY FOR CANCER OF THE TONSILLAR REGION - CLINICAL AND TREATMENT PARAMETERS AS PROGNOSTIC FACTORS [J].
BATAINI, JP ;
ASSELAIN, B ;
JAULERRY, C ;
BRUNIN, F ;
BERNIER, J ;
PONTVERT, D ;
LAVE, C .
RADIOTHERAPY AND ONCOLOGY, 1989, 14 (04) :265-277
[3]   Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis [J].
Browman, GP ;
Hodson, DI ;
Mackenzie, RJ ;
Bestic, N ;
Zuraw, L .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (07) :579-589
[4]  
COREY JP, 1986, ARCH OTOLARYNGOL, V112, P437
[5]   Case-control study of human papillomavirus and oropharyngeal cancer [J].
D'Souza, Gypsyamber ;
Kreimer, Aimee R. ;
Viscidi, Raphael ;
Pawlita, Michael ;
Fakhry, Carole ;
Koch, Wayne M. ;
Westra, William H. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1944-1956
[6]   Conformal re-irradiation of recurrent and new primary head-and-neck cancer [J].
Dawson, LA ;
Myers, LL ;
Bradford, CR ;
Chepeha, DB ;
Hogikyan, ND ;
Teknos, TN ;
Terrell, JE ;
Wolf, GT ;
Eisbruch, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (02) :377-385
[7]  
EMAMI B, 1987, LARYNGOSCOPE, V97, P85
[8]   Changing patterns of tonsillar squamous cell carcinoma in the United States [J].
Frisch, M ;
Hjalgrim, H ;
Jæger, AB ;
Biggar, RJ .
CANCER CAUSES & CONTROL, 2000, 11 (06) :489-495
[9]   A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 [J].
Fu, KK ;
Pajak, TF ;
Trotti, A ;
Jones, CU ;
Spencer, SA ;
Phillips, TL ;
Garden, AS ;
Ridge, JA ;
Cooper, JS ;
Ang, KK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :7-16
[10]   PRIMARY AND SALVAGE SURGERY FOR CANCER OF THE TONSILLAR REGION - A RETROSPECTIVE STUDY OF 120 PATIENTS [J].
GEHANNO, P ;
DEPONDT, J ;
GUEDON, C ;
KEBAILI, C ;
KOKA, V .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (03) :185-189